Researchers are developing inhibitors or agonists targeting specific lncRNAs (e.g., HOTAIR, MALAT1) and circRNAs (e.g., circRNA CDR1as) to restore or suppress their functions, inhibiting cancer cell proliferation and metastasis (141). Here, HOTAIR is linked to cancer.